TetraSilver TetrOxide ( TSTO )



"The Most Powerful Known Antipathogen"


TetraSilver TetrOxide ( TSTO ) is a new class of chemical called "Molecular Battery". It works against pathogens by electrocuting, oxygenating, and chelating the target. It has no interactions with other medications.

TSTO is very effective against many types of virus and bacteria, killing them within a few minutes at very low concentrations.
It is a patented, proven effective treatment for : Acute amoebic dysentery ...  Systemic Candida albicans ... Micrococcus Luteus ... Staphylococcus aureus ... S. epidermidis ... Streptococcus faecalis ...  S.. pyogenes ...Pseudomonas aeruginosa ... Saccharomycetpideae ... Athlete's Foot ... Toenail Fungus ... Skin Conditions ( Dermatitis, Acne, Psoriasis,  Herpes, Skin ulcers ) ... Klebsiella pneumoniae ... Aerobacter aerogenes ... Campylobacter brevis ... Clostridium ... Bacillus species ... Giardia ... Cryptosporidium ... Conjunctivitis ... Chickenpox ... Shingles ...  Ringworm ... Cancer ... AIDS, &c...

TSTO was tested by 14 independent research labs against gram-negative bacteria, gram-positive bacteria, fungi, yeast, and viruses. The labs included Quintiles, Parexel, MDS/Pharma, and other renowned research organizations. TSTO is EPA-approved as a disinfectant in swimming pools; the EPA also determined that TSTO to be safe.

US6485755 : Methods of Using Electron Active Compounds for Managing Cancer -- "...The effects of the electron transfer [ by ] the tetroxide, rendered it a more powerful germicide than other silver entities... they pale by comparison to the tetroxide and so does colloidal silver... The other unique property of the tetroxide was that it did not stain organic matter such as skin... In addition, it was light stable."

Application

Stir TSTO in water ( e.g., 1 mg TSTO in 1 cup water ), add a few drops of hydrogen peroxide ( 3% ), and administer ( oral, nasal, dermal, rectal ).
USP#5571520, "Molecular Crystal Redox Device for Pharmaceuticals", notes: "...It was found that oxidizing agents, particularly persulfates, enhance the efficacy of said devices." Technical Grade TSTO contains trace amounts of Oxone (K-Peroxysulfate) as an activator, and K-/Na-Sulfate as stabilizer.

Acute Oral Toxicity
-- LD.sub.50 Greater than 5,000 mg/Kg ; Acute Dermal Toxicity -- LD.sub.50 Greater than 2,000 mg/Kg ; Primary Eye Irritation -- Mildly irritating ; Primary Skin Irritation -- No irritation ; Skin Sensitization -- Non-Sensitizing

NOT FOR INJECTON !!! Injection requires purification by dialysis, a syringe filter, and supervision by a professional veterinarian. NOT FOR USE IN AQUARIUMS : TSTO can be toxic to fish.

Tools

https://www.rapidtables.com/math/number/PPM.html     PPM ( Parts per Million ) Calculator
https://www.physiologyweb.com/calculators/dilution_calculator_ppb_ppm_ppt_pph.html    Dilution Calculator - ppb, ppm, ppt, pph
https://www.bocsci.com/solution-dilution-calculator.html
    Solution Dilution Calculator -- Dilute Solution of Known Molarity
http://www.rexresearch.com/tetrasilver/tetrasilverindex.html   TSTO Database

Articles & Patents

The "controversy" around TSTO is due to US Patent #5676977 : "Method of Curing AIDS with Tetrasilver Tetroxide Molecular Crystal Devices", which claims that, "When administered into the bloodstream, the device electrons will be triggered by pathogens, a proliferating virus... resulting in divalent silver moieties which chelate and bind active sites of the entities destroying them. The devices are completely non-toxic. However, they put stress on the liver causing hepatomegaly, but there is no loss of liver function... this structural configuration enables intermolecular electron transfer capable of killing viruses and binding them to the resulting silver entity so that a single intravenous injection will completely obliterate acquired immune deficiency syndrome (AIDS) in humans. Furthermore, said devices are capable of killing pathogens and purging the bloodstream of immune suppressing moieties (ISM) whether or not created by the AIDS virus (HIV); so as to restore the immune system... Testing revealed complete 100% destruction of the AIDS virus in vitro at 20 PPM, and the fact that said devices were harmless when ingested and inhaled, being non-toxic."
 
The truth of the claim is well-documented, but suppressed...

US5676977 -- Method of Curing AIDS with Tetrasilver Tetroxide Molecular Crystal Devices
...When administered into the bloodstream, the device electrons will be triggered by pathogens, a proliferating virus... resulting in divalent silver moieties which chelate and bind active sites of the entities destroying them. The devices are completely non-toxic. However, they put stress on the liver causing hepatomegaly, but there is no loss of liver function. The present invention relates to the employment of molecular crystals as anti-AIDS devices, but more particularly to the molecular crystal semiconductor tetrasilver tetroxide Ag4O4 which has two monovalent and two trivalent silver ions per molecule, and which through this structural configuration enables intermolecular electron transfer capable of killing viruses and binding them to the resulting silver entity so that a single intravenous injection will completely obliterate acquired immune deficiency syndrome (AIDS) in humans. Furthermore, said devices are capable of killing pathogens and purging the bloodstream of immune suppressing moieties (ISM) whether or not created by the AIDS virus (HIV); so as to restore the immune system... testing revealed complete 100% destruction of the AIDS virus in vitro at 20 PPM, and the fact that said devices were harmless when ingested and inhaled, being non-toxic. 

http://www.compassion-response.net/08Treatments/05Imusil.htm    Compassion-Response.net
US Patent Claiming CURE for AIDS (USP # 5,676,977)
In October 1977, the United States patented a "method for curing AIDS', US Patent # 5,676,977. The product is called TETRASIL/IMUSIL and is a one-time injection/infusion that eliminates bacterial pathogens in the blood system of an individual. It is this cheap and effective cure for AIDS that is the subject of my presentation.
As a 29-month recipient of this one time injection, I further submit that we have an effective and cheap remedy for AIDS that is ready now. Our goal in bringing this information to the international community is to serve as aconduit for the necessary global "double blind" efficacy clinical trials of this U.S. patented CURE for AIDS.
Independent laboratory and clinical testing indicates that Tetrasil molecules selectively target and kill rapidly proliferating organisms (e.g., cancer cells and pathogenic micro-organisms) through a multitude of nano-level electrical discharges followed by physical combination (chelation), while leaving normal tissues generally unaffected. The unusual suspected kill method may thwart the development of pathogens resistant to Tetrasil therapy.

US20080233161 --
DEPOSITION PRODUCTS, COMPOSITE MATERIALS AND PROCESSES FOR THE PRODUCTION THEREOF
The germicidal properties of silver, even not known as such, have been utilized since the early Mediterranean cultures. It has been known since 1000 BC and possibly before that water kept in silver vessels and then exposed to light and filtered could be rendered potable. Other forms of silver have been used throughout centuries for various applications, such as coatings for prevention of beverages from spoilage or silver plates and foils in the surgical treatments of wounds and broken bones...
Djokie found that an essential factor leading to an antimicrobial activity of metallic silver is a presence of Ag oxide(s) at the surface of this material. It was demonstrated that only silver films containing silver oxides (most likely Ag.sub.2O) showed an antimicrobial activity...

WO2001077030 -- OZONATED SOLUTIONS OF TETRASILVER TETROXIDE
...it appears that in addition to acting as a killing agent in its own right, ozone is surprisingly able to activate the antimicrobial activity of tetrasilver tetroxide, thus yielding a synergistic killing effect exceeding the individual killing effects of either non-activated tetrasilver tetroxide or ozone.
Example 5: Ozone Stability Testing 6.1 mg/L (6.1 ppm) of ozone was provided in deionized, distilled water over a 15 minute period. The solution was allowed to stand with stirring by a magnetic stirrer over a 24-hour period, taking periodic readings of the ozone concentration. By 2 hours, the ozone concentration was 3 ppm and progressively dropped to 0.01 ppm by 18 hours. This represented a half-life of approximately 2 hours. When 2 ppm tetrasilver tetroxide was added, the rate of decay was unexpectedly lengthened, such that 0.12 ppm of ozone was present after 18 hours (approximately an order of magnitude higher than would have been expected in the absence of tetrasilver tetroxide) and by 24 hours, 0.03 ppm of ozone oxidizing activity was still present.

US5336499 -- Molecular Crystal Device for Pharmaceuticals
A novel molecular scale device is described which is bactericidal, fungicidal, viricidal and algicidal. The anti-pathogenic properties of the device are attributed to electron activity indigenous to diamagnetic semiconducting crystals of tetrasilver tetroxide ( Ag4O4 )... When the crystals are activated with an oxidizing agent, they release electrons equivalent to 6.4 x 10-19 watts per molecule which in effect electrocute pathogens. A multitude of these devices are effective at such low concentrations as 0.3 PPM used as preservatives in a variety of formulations ranging from cosmetics to pharmaceuticals. Indeed, they are intended as active ingredients for pharmaceuticals formulated to destroy such pathogens as Staphylococcus aureus, and epidermidis, the latter of which it completely destroys in a nutrient broth culture of about 1 million organisms at 0.6 PPM, or Candida albercans, the vaginal yeast infection at 2.5 PPM, and the AIDS virus at 18 PPM...  [t]he devices were able to kill two strains of E. Coli at 2.5 PPM; Micrococcus Luteus at 1.25 PPM; Staphylococcus aureus at 2.5 PPM; Staphylococcus epidermidis at 0.6 PPM; Pseudomonas aeruginosa at 1.25 PPM; and Streptococcus pyogenes at 2.5 PPM... The infectious yeast pathogen Candida ALBICANS was totally killed at 2.5 PPM and that of the Saccharomycetpideae variety at 1.25 PPM.

US5223149 -- Trivalent Silver Water Treatment Compositions
Said trivalent silver complexes were subsequently evaluated as to their efficacy in killing gram positive and gram negative bacteria in algae in accordance with the EPA protocols for swimming pools, which require 100% kills of bacteria within ten minutes. .. The compounds far exceeded the bacteria requirements at concentrations of one PPM or less of silver. They were evaluated with and without persulfate salts at 10 PPM and were effective without persulfates as bactericides... Ag(III) complexes were applied to human skin in concentrated form containing as much as 5,000 PPM silver without any silver staining of the skin whatsoever.

US Patent 5,211,855 -- Method of Treating Water Employing Tetrasilver Tetroxide Crystals
...When the crystals are activated with an oxidizing agent, they release electrons equivalent to 6.4 x 10-19 watts per molecule which in effect electrocute pathogens. A multitude of these devices are effective at such low concentrations as 0.3 PPM where they can kill 100% of 100 K/cc Streptococcus faecalis, and E. coli colonies in three minutes... When the tetroxide crystals are utilized to destroy pathogens, they will not do so unless activated by an oxidizing agent. The tetroxide was activated by persulfates [ or: hydrogen peroxide ]. It was found that when the persulfates were tested as a control by themselves, they failed to exhibit any unilateral antipathogenic activity at the optimum level selected of 10 PPM. The persulfates evaluated varied from OXONE (Registered Trademark Du Pont Company) brand potassium monopersulfate to alkali peroxydisulfates.

US5571520 -- Molecular Crystal Redox Device for Pharmaceuticals
A method for curing amoebic dysentery comprising, administering crystals of tetrasilver tetroxide intravenously so as to give a concentration of crystals of 40 PPM in the bloodstream... treating systemic Candida albicans; comprising injecting tetrasilver tetroxide crystals into the blood of humans so as to give a concentration of approximately 40 PPM in the bloodstream...  It was found that oxidizing agents, particularly persulfates, enhance the efficacy of said devices.
EXAMPLE 1 ...Staphylococcus aureus and Staphylococcus epidermidis :... it was found that staph organism 9027 was inhibited at 2.5 PPM; number 27543 at 5.0 PPM; and the 2228 organism at 0.625 PPM all in the presence of 10 PPM sodium persulfate...
EXAMPLE 2 ... Yeast pathogen Candida albicans : The douche which contained 10 PPM of crystals and 40 PPM sodium persulfate was self-administered ... After taking two 2-quart douches within 24 hours, all signs of the candida infection had disappeared and her doctor pronounced her completely cured.
EXAMPLE 3 ... Candida albicans. The subject, a citizen and resident of Honduras, was a 33-year old female. She was completely cured within a month of taking the crystals intravenously. It should be noted that the subject was close to death as a consequence of exposure to the disease prior to the aforesaid treatment.
EXAMPLE 4 ... Acute ameobic dysentery with diarrhea and dehydration : ...after being given one injection started to show slight improvement after one week. After one month had elapsed, they were completely cured from their condition.
EXAMPLE 6 ... A 29-year old male suffering from athlete's foot soaked his feet in a solution containing 100 PPM of the crystal devices. The subject was completely cured within 24 hours.
EXAMPLE 7 ... A 61-year old male who suffered from a toenail fungus was treated with a 25% suspension of said crystal devices. The nail fungus, which had bothered the subject for three years, was gone after a week.

US6258385 -- Tetrasilver Tetroxide Treatment for Skin Conditions
The invention relates to the use of electron active molecular crystals comprising tetrasilver tetroxide (Ag.sub.4 O.sub.4) for the treatment and cure of dermatological skin conditions (diseases) ranging from dermatitis, acne and psoiasis to herpes and skin ulcers.

CN101336640 -- Tetrasilver tetroxide bactericide, preparation method and use thereof
The tetrasilver tetroxide fungicide comprises the following components by weight part: weak alkaline solution 800-1200 parts, tetrasilver tetroxide 0.1-0.5 parts, and polyvinyl alcohol 8-20 parts. Beneficial effects: ...The preparation method of the present invention is simple, suitable for large Scale industrial production, application method is simple and practical.

US5098582 -- Divalent Silver Oxide Bactericides
Divalent silver oxide provides a source for divalent bactericidal silver ions in the presence of persulfate. This oxide is especially effective when applied to water used in industrial cooling towers, hot tubs and swimming pools and conforms to stringent EPA requirements of 100% kills of 100K/cc Streptococcus faecalis within 10 minutes. The oxide also can be used in water with exceptionally high salt content without halide curdy precipitate formation and will not stain the skin of users who may inadvertently be exposed to it.

US5089275 -- Stabilized Divalent Silver Bactericides
Solid bactericidal compositions are disclosed based on divalent silver (Ag(II)) as the active sanitized agent. The compositions are prepared by reacting acid liquid Ag(II) complexes with anhydrous calcium sulfate so as to form a solid matrix in which the bactericide is entrapped in the resulting hydrated calcium sulfate. Optimum compositions are described consisting of Ag(II) phosphate dissolved in phosphoric acid where the ratio of solid (by weight) to liquid (by volume) is 5:2. The resulting solid bactericides can be used in water cooling installations. They are capable of causing 100% kills within 10 minutes of E. Coli conforms in conformity with EPA protocols, allowing them to quality as swimming pool and hot tub sanitizers. Since the compositions are based on calcium sulfate, they are also suitable as mineralizers, thus providing a dual function.

US2006105057 -- Compositions using tetrasilver tetroxide and methods for management of skin conditions using same
Dermatological conditions and diseases that may be prevented, treated, or managed with the compositions of the invention include : eczema, psoriasis, dermatitis, disease-induced skin ulcers, undefined tropical diseases, shingles, rashes, bedsores, cold sores, blisters, boils, herpes simplex, acne, pimples, skin chafing, skin cracking, itchiness, skin peeling, and warts.

US6258385 -- Tetrasilver tetroxide treatment for skin conditions
The invention relates to the use of electron active molecular crystals comprising tetrasilver tetroxide (Ag4O4) for the treatment and cure of dermatological skin conditions (diseases) ranging from dermatitis, acne and psoiasis to herpes and skin ulcers. 

WO2001077030 -- OZONATED SOLUTIONS OF TETRASILVER TETROXIDE
The ozonated form of the compound tetrasilver tetroxide has an antimicrobial effect greater than that of non-oxidated tetrasilver tetroxide..In embodiments of the invention, ozonated tetrasilver tetroxide has an antimicrobial effect at least equal to that of potassium monopersulfate-activated tetrasilver tetroxide.

https://www.ncbi.nlm.nih.gov/pubmed/20657533    Panminerva Med. 2010 Jun;52(2 Suppl 1):37-42.
Belcaro G, et al.: Venous and diabetic ulcerations: management with topical multivalent silver oxide ointment
CONCLUSION: This pilot study provides observational data on the efficacy of local treatment of ulcers with a multivalent silver oxide containing ointment. The silver ointment improved microcirculation and the healing rate of all 78 patients that were treated with multivalent silver ointment and closed twice as many ulcers in 4 weeks compared to the control groups (40.7% silver treatment compared to 19.4% for the control). This study demonstrates the feasibility of this type of treatment and provides evidence of efficacy to plan larger randomized controlled studies. The large number of patients that were helped in this study demonstrates the efficacy of multivalent silver oxide topical ointment and its important role in ulcer therapy.

https://www.ncbi.nlm.nih.gov/pubmed/22108474     Panminerva Med. 2011 Sep;53(3 Suppl 1):29-33.
Belcaro G, et al.: Silver oxide ointment wound dressing in venous ulcerations: home, self-management
After four weeks, treatment with the Silver Oxide Ointment proved more effective than the 'best management' used in controls... The silver oxide ointment improved both the microcirculation and the healing rate of their ulcers. No significant tolerability problems were observed.

https://www.ncbi.nlm.nih.gov/pubmed/21861623     Future Microbiol. 2011 Aug;6(8):933-40. doi: 10.2217/FMB.11.78.
Allahverdiyev AM, et al.: Antimicrobial effects of TiO(2) and Ag(2)O nanoparticles against drug-resistant bacteria and leishmania parasites.
Metal oxide nanoparticles, especially TiO(2) and Ag(2)O nanoparticles, have demonstrated significant antibacterial activity. Therefore, it is thought that this property of metal oxide nanoparticles could effectively be used as a novel solution strategy. In this review, we focus on the unique properties of nanoparticles, their mechanism of action as antibacterial agents and recent studies in which the effects of visible and UV-light induced TiO(2) and Ag(2)O nanoparticles on drug-resistant bacteria have been documented. In addition, from to previous results of our studies, antileishmanial effects of metal oxide nanoparticles are also demonstrated, indicating that metal oxide nanoparticles can also be effective against eukaryotic infectious agents. Conversely, despite their significant potential in antimicrobial applications, the toxicity of metal oxide nanoparticles restricts their use in humans. However, recent studies infer that metal oxide nanoparticles have considerable potential to be the first-choice for antibacterial and antiparasitic applications in the future, provided that researchers can bring new ideas in order to cope with their main problem of toxicity.


-